![Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-020-01890-6/MediaObjects/12974_2020_1890_Fig1_HTML.png)
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text
![JCI - Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer JCI - Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer](https://dm5migu4zj3pb.cloudfront.net/manuscripts/11000/11914/medium/JCI0111914.f1.jpg)
JCI - Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
![PDF] Nuclear factor-kappa-B-inhibitor alpha (NFKBIA) is a developmental marker of NF-κB/p65 activation during in vitro oocyte maturation and early embryogenesis. | Semantic Scholar PDF] Nuclear factor-kappa-B-inhibitor alpha (NFKBIA) is a developmental marker of NF-κB/p65 activation during in vitro oocyte maturation and early embryogenesis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2e63761ec1bcb3cbed1c5924b4290442dbb1ca17/3-TableI-1.png)
PDF] Nuclear factor-kappa-B-inhibitor alpha (NFKBIA) is a developmental marker of NF-κB/p65 activation during in vitro oocyte maturation and early embryogenesis. | Semantic Scholar
Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner - Chemical Communications (RSC Publishing)
![Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System](https://pub.mdpi-res.com/cells/cells-10-01335/article_deploy/html/images/cells-10-01335-g001.png?1622186861)
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
![The NF‐κB Pathway. IKKs, inhibitor of kappa B kinases; IκB, IkappaB;... | Download Scientific Diagram The NF‐κB Pathway. IKKs, inhibitor of kappa B kinases; IκB, IkappaB;... | Download Scientific Diagram](https://www.researchgate.net/publication/363866652/figure/fig3/AS:11431281109725548@1672185830672/The-NF-kB-Pathway-IKKs-inhibitor-of-kappa-B-kinases-IkB-IkappaB-IL-interleukin.png)
The NF‐κB Pathway. IKKs, inhibitor of kappa B kinases; IκB, IkappaB;... | Download Scientific Diagram
![The nuclear factor – kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease - ScienceDirect The nuclear factor – kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049384811001526-gr1.jpg)
The nuclear factor – kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease - ScienceDirect
![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![Insights into the mechanism of natural terpenoids as NF-κB inhibitors: an overview on their anticancer potential | Experimental oncology Insights into the mechanism of natural terpenoids as NF-κB inhibitors: an overview on their anticancer potential | Experimental oncology](http://exp-oncology.com.ua/wp/wp-content/uploads/2016/09/wpid-2294_02_fmt.jpeg)